May 09 Watch 6:48 This Cuban lung cancer drug is giving some U.S. patients hope By PBS News Hour A promising lung cancer treatment from Cuba is getting attention from U.S. patients, some of whom are already traveling there to try the drug in hopes of stopping their cancer from growing. American doctors can't prescribe CIMAvax because the Food… Continue watching
Dec 06 Watch 9:16 Major health bill would fund medical research, hasten FDA approvals By PBS News Hour In Congress, lawmakers are close to passing a major bill that would increase funding for the FDA, the NIH and the effort to fight opioid abuse. The measure would also introduce more flexible standards for drug approvals, reducing the need… Continue watching
Dec 06 Who wins and loses with the 21st Century Cures Act? By Sheila Kaplan, STAT More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies. Continue reading
Dec 01 Using Ecstasy to treat PTSD: ‘I felt like my soul snapped back into place’ By Caleb Hellerman, Global Health Reporting Center On Tuesday, the Food and Drug Administration gave an important boost to a therapy that uses MDMA, commonly known as ecstasy, to treat PTSD, clearing the way for one or more large-scale research studies. Since 2004, more than 100 patients… Continue reading
Nov 02 FDA to America: How much Nutella do you eat? By Megan Thielking, STAT The U.S. Food and Drug Administration is gathering information on the amount of Nutella that constitutes a reasonable serving size. Continue reading
Sep 30 How one drug company fast-tracked the FDA’s review process By Sarah Jane Tribble, Kaiser Health News Any company awarded a voucher can use it for a fast-track government review of one of its future drugs — or it can sell the voucher to another company. Continue reading
Sep 20 After fierce debate, FDA approves first drug for rare form of muscular dystrophy By Liz Szabo, Kaiser Health News The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease. Continue reading
Sep 11 FDA weighs crackdown that could shut hundreds of stem cell clinics By Usha Lee McFarling, STAT Scientists on Monday will urge the Food and Drug Administration to crack down on rogue clinics across the country that market stem cell treatments. Continue reading
Sep 10 Allergy-proof? Intelligence booster? FDA looks to rein in health claims for baby formula By Sheila Kaplan, STAT The FDA suggested this week that the $3 billion infant formula industry consider proving its claims before selling the products. Continue reading
Sep 09 FDA expresses concern over widely used ovarian cancer screening test By Sheila Kaplan, STAT The Food and Drug Administration on Wednesday warned women and their doctors that current screening tests for ovarian cancer are unreliable. Continue reading